Ciheptolane

This classification denotes an antihypertensive agent and analgesic agent with the molecular formula C20H23NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NLD2X0VD2U, chemically known as 10,11-dihydro-n,n-dimethylspiro(5h-dibenzo(a,d)cycloheptene-5,2-(1,3)dioxolane)-4-methylamine. but generally known as ciheptolane, which bears US NIH Compound Identifier 115697. European Medicines Agency schedules Ciheptolane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06261MIG. The term CIHEPTOLANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). CIHEPTOLANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ciheptolane under HS 29329970 and SITC 51569. As of Q4 2014, CIHEPTOLANE remains the US FDA Preferred Term for this commodity. Ciheptolane bears US NLM identifiers UMLS ID C2699211 and NCI Concept Code C77318. SMILES: O1C2(OCC1CN(C)C)c1c(CCc3c2cccc3)cccc1.